FDA Inspection 863396 — Cadila Healthcare Limited

Cadila Healthcare Limited — FEI 3010491901

The FDA completed an inspection of Cadila Healthcare Limited on Jan 10, 2014 in Pennington, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 10, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pennington, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
720921 CFR 50.25(a)(1)Procedures, identification of those which were experimental
748021 CFR 312.50Ensuring compliance with plan and protocol
748221 CFR 312.50General responsibilities of sponsors

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.